SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-075201
Filing Date
2024-06-26
Accepted
2024-06-26 16:47:40
Documents
19
Period of Report
2024-04-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2418216d1_8ka.htm   iXBRL 8-K/A 32298
2 EXHIBIT 23.1 tm2418216d1_ex23-1.htm EX-23.1 3708
3 EXHIBIT 99.1 tm2418216d1_ex99-1.htm EX-99.1 355471
4 EXHIBIT 99.2 tm2418216d1_ex99-2.htm EX-99.2 156796
8 GRAPHIC image_003.jpg GRAPHIC 2808
9 GRAPHIC image_004.jpg GRAPHIC 2198
10 GRAPHIC tm2418216d1_ex23-1img001.jpg GRAPHIC 8980
  Complete submission text file 0001104659-24-075201.txt   815934

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20240411.xsd EX-101.SCH 3018
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20240411_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20240411_pre.xml EX-101.PRE 22361
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2418216d1_8ka_htm.xml XML 4209
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40498 | Film No.: 241074246
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)